Skip to Main content Skip to Navigation
Journal articles

Plasticité phénotypique et thérapies ciblées dans les cancers bronchiques non à petites cellules

Abstract : Lung cancer is the most diagnosed and deathly type of cancer worldwide. It has a poor prognosis because of a late diagnosis, high metastatic potential and resistance to conventional therapies. Since the 2000s, the emergence of targeted therapies has improved patients' outcomes. However, these therapies concern only a small proportion of patients, selected by the presence of molecular biomarkers that indicate the targeting relevance. Here, we discuss the possibility that new phenotypical biomarkers could be predictive factors for targeted therapies in lung cancer.
Document type :
Journal articles
Complete list of metadatas

Cited literature [20 references]  Display  Hide  Download

https://hal.univ-reims.fr/hal-02448654
Contributor : Valerian Dormoy <>
Submitted on : Friday, April 10, 2020 - 3:51:50 PM
Last modification on : Friday, April 17, 2020 - 2:29:11 PM

File

DaSilvaJordan_RMR_2019.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Jordan da Silva, Véronique Dalstein, Myriam Polette, Béatrice Nawrocki-Raby. Plasticité phénotypique et thérapies ciblées dans les cancers bronchiques non à petites cellules. Revue des Maladies Respiratoires, Elsevier Masson, 2019, 36 (4), pp.438-441. ⟨10.1016/j.rmr.2019.03.004⟩. ⟨hal-02448654⟩

Share

Metrics

Record views

75

Files downloads

79